Key takeaways
Farxiga (dapagliflozin) and Actos (pioglitazone) are both medications used to manage Type 2 diabetes, but they have several differences between them. Farxiga helps lower blood sugar by causing your body to release excess sugar through urine. It also has benefits for heart failure and chronic kidney disease (CKD). Actos, on the other hand, improves your body's ability to use insulin. While both medications are usually taken once daily, Farxiga can also be used help treat heart and kidney issues. Taking Farxiga can cause dehydration and increase the risk of urinary tract infections, while Actos can lead to weight gain, fluid build-up, and a increased risk of bladder cancer. Additionally, Farxiga is only available as a brand medication, whereas Actos is available as a lower cost generic.
